- Category
- Micro (2021-22)
- Udyam number
- UDYAM-KR-03-0059174

Zoobion Pharmaceuticals Private Limited
About Zoobion Pharmaceuticals Private Limited
Data last updated:
Zoobion Pharmaceuticals Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 27 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24234KA2021PTC144700.
The company has an authorised share capital of ₹8 Lakh and a paid-up capital of ₹54,000. It is led by directors Pooja Pandya and Gaurav Vyas.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ng304 North Block Shriram Smrithi Bidarguppe Village Attibele Hobli Anekal, Bengaluru, Karnataka, India – 562107.
As per the financials filed for FY 2024, the company reported a revenue of ₹43.56 Lakh, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹15,618 (net margin 0.4%) and EBITDA of ₹1.44 Lakh (EBITDA margin 3.3%).
As per MCA filings, the company has open charges of ₹10 Lakh on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Zoobion Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0059174).
Company details
Recognitions & Rankings of Zoobion Pharmaceuticals
Contact details
Zoobion Pharmaceuticals Private Limited's registered office is in Bengaluru, Karnataka.
- Social Media
- Registered AddressNg304 North Block Shriram Smrithi Bidarguppe Village Attibele Hobli Anekal, Bengaluru, Karnataka, India – 562107
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zoobion Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Zoobion Pharmaceuticals Private Limited, buy the company report.
Financials of Zoobion Pharmaceuticals Private Limited
FY 2025 filings availableZoobion Pharmaceuticals Private Limited reported revenue of ₹43.56 Lakh (up 24% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 24% in the latest year. EBITDA fell 33% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.44 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹15,618 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.3% | |||
| Net Profit Margin | 0.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Zoobion Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zoobion Pharmaceuticals Private Limited
Zoobion Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pooja Pandya | Director | 27 Feb 2021 | 5 Years 8 Months | Current |
| Gaurav Vyas | Director | 27 Feb 2021 | 5 Years 8 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Aug 2021 | 100468679 | State Bank of India | ₹10 Lakh | Open |
To see the full charge records of Zoobion Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Zoobion Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Sun Pharma Laboratories Limited | Pending |
To see the full case history of Zoobion Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zoobion Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Zoobion Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Zoobion Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Gaurav Vyas was appointed as Director on 27 Feb 2021.
Frequently asked questions
Zoobion Pharmaceuticals is an active private limited company based in Bengaluru, Karnataka, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 27 February 2021 (5+ years old) and is registered under CIN U24234KA2021PTC144700.
Zoobion Pharmaceuticals has 2 current directors:
- Pooja Pandya - Director
- Gaurav Vyas - Director
The latest financial statements of Zoobion Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Zoobion Pharmaceuticals is U24234KA2021PTC144700. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zoobion Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Zoobion Pharmaceuticals was incorporated on 27 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
Gaurav Vyas was appointed as Director on 27 Feb 2021. Pooja Pandya was appointed as Director on 27 Feb 2021.
Yes, Zoobion Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0059174).
The registered office of Zoobion Pharmaceuticals is at Ng304 North Block Shriram Smrithi Bidarguppe Village Attibele Hobli Anekal, Bengaluru, Karnataka, India – 562107.
Zoobion Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

